Status:
COMPLETED
Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache
Lead Sponsor:
Sorlandet Hospital HF
Conditions:
Headache
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether prednisolone is more effective than placebo in the first six days after initiation of medication withdrawal therapy for a medication overuse headache....
Detailed Description
Data published BoeMG,Mygland A,Salvesen R; Neurology 2007 Jul 3;69(1):26-31
Eligibility Criteria
Inclusion
- Chronic daily headache and medication overuse fulfilling International Headache Society (IHS)-II criteria
Exclusion
- Pregnancy
- Age under 18 and over 70 years
- Major mental disorders
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00135122
Start Date
September 1 2003
End Date
January 1 2007
Last Update
September 12 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sørlandet Sykehus HF
Kristiansand, Vest-Agder, Norway, 4604